Kronos Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Kronos Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q2 2024.
- Kronos Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.2M, a 68.1% decline year-over-year.
- Kronos Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $21.4M, a 25.4% decline year-over-year.
- Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $25M, a 19.8% decline from 2022.
- Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31.1M, a 18.8% increase from 2021.
- Kronos Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $26.2M, a 598% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)